Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

Mangge, H; Heinzl, B; Grubbauer, HM; El-Shabrawi, Y; Schauenstein, K.
Therapeutic experience with infliximab in a patient with polyarticular juvenile idiopathic arthritis and uveitis.
Rheumatol Int. 2003; 23(5):258-261 Doi: 10.1007/s00296-003-0308-1 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Leading authors Med Uni Graz
Mangge Harald
Co-authors Med Uni Graz
El-Shabrawi Yosuf
Grubbauer Hans
Schauenstein Konrad
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
A pediatric patient with prolonged seronegative polyarticular juvenile idiopathic arthritis (JIA) and concomitant aggressive, anterior uveitis refractory to any conventional antirheumatic therapy was treated with infliximab. Arthritis and C-reactive protein (CRP) values showed prompt positive effects but, after 6 weeks, returned gradually to initial values despite ongoing therapy. In contrast, a more sustained therapeutic effect was observed on the uveitis, with increased visual acuity and reduced inflammatory signs of the affected eye. However, this benefit was also lost at week 30, after which infliximab had to be discontinued due to side effects. To conclude, in polyarticular seronegative JIA, infliximab showed a transient beneficial effect which was more pronounced on uveitis than arthritis.
Find related publications in this database (using NLM MeSH Indexing)
Adolescent -
Antibodies, Monoclonal - therapeutic use
Antirheumatic Agents - therapeutic use
Arthritis, Juvenile Rheumatoid - complications Arthritis, Juvenile Rheumatoid - drug therapy Arthritis, Juvenile Rheumatoid - immunology
C-Reactive Protein - immunology
Humans -
Male -
Severity of Illness Index -
Treatment Failure -
Uveitis, Anterior - complications Uveitis, Anterior - drug therapy Uveitis, Anterior - immunology

Find related publications in this database (Keywords)
infliximab
juvenile idiopathic arthritis
treatment
uveitis
© Med Uni GrazImprint